Compugen Ltd. said Martin Gerstel will step down from its board Feb. 2.
Gerstel will assume the role of senior adviser to the Israeli drug discovery company's chairman.
Compugen director to resign
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Compugen Ltd. said Martin Gerstel will step down from its board Feb. 2.
Gerstel will assume the role of senior adviser to the Israeli drug discovery company's chairman.